A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

NCT03531931 ·Status: UNKNOWN

The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer

NCT03154983 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy

NCT05029453 ·Status: UNKNOWN ·Phase: PHASE4

Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer

NCT02537171 ·Status: UNKNOWN ·Phase: PHASE3

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

NCT02485015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer

NCT03334591 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

NCT03271073 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

NCT03950141 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

NCT03276156 ·Status: UNKNOWN ·Phase: PHASE1

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

NCT02510469 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer

NCT02668380 ·Status: UNKNOWN

PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma

NCT04006821 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer

NCT02697838 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA

NCT03116555 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

NCT00970138 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

NCT02509806 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

NCT02764268 ·Status: COMPLETED ·Phase: NA

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

NCT01512745 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

NCT03598348 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

NCT02776527 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

NCT02775370 ·Status: UNKNOWN ·Phase: PHASE2

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

NCT03144843 ·Status: UNKNOWN ·Phase: PHASE2

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

NCT03889626 ·Status: UNKNOWN ·Phase: PHASE3

Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)

NCT02596256 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma

NCT03071042 ·Status: UNKNOWN ·Phase: PHASE1